New Health Capital builds royalties fund
The New York-based private equity firm has collected $150m for investments in pharmaceutical products and medical device companies that will employ strategies like royalty monetisation.
The New York-based private equity firm has collected $150m for investments in pharmaceutical products and medical device companies that will employ strategies like royalty monetisation.
Copyright PEI Media
Not for publication, email or dissemination